Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a ...

According to Politico, Trump will issue an executive order in the next few days to pursue the use of a so-called 'most ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

In Part 6 of the Life Sciences Industry Report, we’ve collated key thought leadership from 2024 that looks at ways in which ...

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...